Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Delayed PRP treatment may help ACL healing in older patients.

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

Clouston syndrome is inherited in an autosomal dominant pattern and caused by a specific gene mutation, with no current treatment available.

p63 is essential for skin cell growth and differentiation by controlling specific gene networks.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

ECCL should be considered in patients with specific skin and eye lesions.

MFN2 mutations cause mitochondrial problems, leading to more upper body fat and lower leptin levels.

Beta-HPV and MCPyV are linked to certain skin cancers, with ongoing research and vaccine development.

A gene mutation in mice causes skin defects and early death.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

Mice with a specific BRCA1 mutation have a higher risk of tumors, especially in the uterus and ovaries.

People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

The HCR gene contributes to psoriasis risk.

Patched1 helps prevent tumors by controlling cell growth.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

High LGR5 levels in glioblastoma indicate poor prognosis and are essential for cancer stem cell survival.

Deleting TNFα gene reduces skin cancer risk in certain mice.

mIGF-1 in skin cells speeds up wound healing and hair growth in mice without harmful effects.

Certain genes are linked to the risk of developing Alopecia Areata.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

Melanocyte pathology requires keratinocyte hyperplasia and regulation dysfunction.

MPZL3 protein is important for controlling hair growth cycles.